Foresite Capital Management Iii, LLC Verona Pharma PLC Transaction History
Foresite Capital Management Iii, LLC
- $37.9 Million
- Q3 2022
A detailed history of Foresite Capital Management Iii, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Foresite Capital Management Iii, LLC holds 1,111,112 shares of VRNA stock, worth $38 Million. This represents 29.98% of its overall portfolio holdings.
Number of Shares
1,111,112
Previous 1,111,112
-0.0%
Holding current value
$38 Million
Previous $4.66 Million
143.9%
% of portfolio
29.98%
Previous 16.89%
Shares
11 transactions
Others Institutions Holding VRNA
# of Institutions
145Shares Held
66.8MCall Options Held
495KPut Options Held
486K-
Ra Capital Management, L.P. Boston, MA7.63MShares$261 Million1.66% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$191 Million7.62% of portfolio
-
Deep Track Capital, LP Greenwich, CT4MShares$137 Million1.9% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$121 Million7.58% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.31MShares$113 Million2.82% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $2.08B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...